Intra-Cellular Therapies
 |
|
Website |
www.intracellulartherapies.com |
Sector Group |
Health Care and Sciences |
Fund Relationship |
Alafi Capital |
Description |
A biopharmaceutical company focused on the development of novel drugs for the treatment of schizophrenia, depression, Parkinson’s and Alzheimer’s diseases. The company’s core technology is based on the scientific work of Dr. Paul Greengard, a Nobel-prize winning scientist at New York’s Rockefeller University. In June 2007, the company initiated Phase I clinical trials for a series of compounds focused on the treatment of schizophrenia and sleep disorders. Intra-Cellular Therapies is currently headquartered in the Audubon Technology Park (Columbia University’s incubator) in Washington Heights. |